Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Treatment with Soluble CD24 Attenuates COVID-19-Associated Systemic Immunopathology

medRxiv(2021)10.1101/2021.08.18.21262258Source: DataRank Database

Treatment with Soluble CD24 Attenuates COVID-19-Associated Systemic Immunopathology is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (48)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (30)

Carter Allen ORCID,Anna E. Vilgelm ORCID,Brian Riesenberg ORCID,Kevin P. Weller,Kelsi Reynolds ORCID

Live enrichment

PubMed:34462760 OpenAlex:https://openalex.org/W3194565101

National Institutes of Health

Grant: 5R37CA233770-04

Combining senescence-inducing and senolytic agents to improve melanoma therapy

National Institutes of Health

Grant: 7R01AI077283-14

Molecular chaperones and immune tolerance

National Institutes of Health

Grant: 5R01CA213290-05

Integration of inflammation and cancer by molecular chaperone

National Institutes of Health

Grant: 3P30CA016058-15S1

CORE--HORMONE RECEPTOR LABORATORY

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/09/16/2021.08.18.21262258.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.08.18.21262258

repositoryhttps://doi.org/10.1101/2021.08.18.21262258

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34462760

Fields of Study

COVID-19 Clinical Research StudiesCancer Immunotherapy and BiomarkersImmune Cell Function and Interaction03 medical and health sciences0302 clinical medicine

Keywords

Systemic inflammationImmunologyImmune systemCytokinePeripheral blood mononuclear cellFlow cytometryMedicineInflammationCD8ChemokineAntibodyPlaceboBiologyPathologyIn vitroMaleT-LymphocytesCD24FcCytokine scoreArticleImmunophenotypingDouble-Blind MethodAlarminsHomeostasisHumansDiseases of the blood and blood-forming organsHMGB1 ProteinRC254-282Heat-Shock ProteinsAgedSARS-CoV-2ResearchNeoplasms. Tumors. Oncology. Including cancer and carcinogensCD24 AntigenCOVID-19Middle AgedKiller Cells, NaturalSoluble CD24Treatment OutcomeSolubilityFemaleRC633-647.5Cytokine Release Syndrome

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Treatment with Soluble CD24 Attenuates COVID-19-Associated Systemic Immunopathology

FAIR Checklist

Authors (30)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)